secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROKIDNEY CORP. (PROK)
CIK:        0001850270
Form:       8-K
Filed at:   2022-07-15T23:59:59+00:00
Accession:  0001193125-22-195148
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 9.01, 5.02, 4.01, 3.02, 3.03, 5.01, 5.03, 5.06, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ProKidney completes de-SPAC merger; begins trading as PROK on Nasdaq
--------------------------------------------------------------------

- Social Capital Suvretta Holdings Corp. III merged with ProKidney LP; renamed ProKidney Corp.
- ~22.8M public shares redeemed at ~$10.00 each, leaving ~$21.7M in trust post-closing.
- Outstanding equity after close: 9.06M Class A shares from SPAC holders and 52.48M Class A shares from PIPE.
- Class A ordinary shares began trading under ticker PROK on Nasdaq on July 12, 2022.
- Lock-up restrictions range from 30 days to 4 years, with earn-out milestones at $12.50 and $15.00 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850270/000119312522195148/0001193125-22-195148-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850270/000119312522195148/d285643d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-195148

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer